microRNAs as Biomarkers of Breast Cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Breast cancer (BC) is the most prevalent cancer in women, necessitating early detection for improved outcomes.
• Early diagnosis of breast cancer is critical for effective treatment and favorable prognosis.
• MicroRNAs (miRNAs) are implicated in the initiation and progression of breast cancer.

Purpose of the Study:

• To review the significance and potential of microRNAs as biomarkers for early breast cancer detection.
• To explore the utility of miRNAs in predicting disease course and evaluating treatment efficacy.
• To highlight the role of miRNAs in the etiology of breast cancer development.

Main Methods:

• Literature review focusing on microRNA research in breast cancer.
• Analysis of studies investigating serum microRNA signatures for breast cancer detection.
• Discussion of miRNA stability and detection in biological fluids.

Main Results:

• MicroRNAs are small, single-stranded RNA molecules that regulate gene expression and play a role in cancer development.
• Cancer cells harbor specific miRNAs involved in the etiology of breast cancer.
• MicroRNAs exhibit high stability, enabling their detection in various biological fluids like serum.
• Multiple serum microRNA signatures have been identified as potential biomarkers for breast cancer.

Conclusions:

• MicroRNAs hold significant potential as molecular tools for the early detection of breast cancer.
• The stability and detectability of miRNAs in serum support their use as diagnostic biomarkers.
• Further research into miRNA signatures can advance early diagnosis, prognosis, and treatment assessment for breast cancer.